Molecular genetics of dilated cardiomyopathy

Current Opinion in Cardiology

Volumn 12, Issue 3, 1997, Pages 303-309

  Mestroni, Luisa ^a   Giacca, Mauro ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSKELETON PROTEIN; DYSTROPHIN;

AUTOSOMAL DOMINANT INHERITANCE; FAMILIAL DISEASE; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENETIC HETEROGENEITY; HEART DILATATION; MOLECULAR GENETICS; PRIORITY JOURNAL; REVIEW;

EID: 0030905703     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-199705000-00012     Document Type: Review

References (47)

1. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996, 93:841-842. Update of the official nomenclature and classification of primary and secondary cardiomyopathies.
2. Giacca M, Severini GM, Mestroni L, Salvi A, Lardieri G, Falaschi A, Camerini F: Low frequency of detection by nested polymerase chain reaction of enterovirus ribonucleic acid in endomyocardial tissue of patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1994, 24:1033-1040.
3. Fuster V, Gersh BJ, Giuliani ER, Tajik AJ, Brandenburg RO, Frye RL: The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 1981, 47:525-531.
4. Michels VV, Driscoll DJ, Miller FA: Family aggregation of idiopathic dilated cardiomyopathy. Am J Cardiol 1985, 55:1232-1233.
5. Mestroni L, Miani D, Di Lenarda A, Silvestri F, Bussani R, Filippi G, Camerini F: Clinical and pathologic study of familial dilated cardiomyopathy. Am J Cardiol 1990, 65:1449-1453.
6. Michels VV, Moll PP, Miller FA, Tajik AJ, Chu JS, Driscoll DJ, Burnelt JC, Rodeheffer RJ, Chesebro JH, Tazelaar H: The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med 1992, 326:77-82.
7. Keeling PJ, Gang G, Smith G, Seo H, Bent SE, Murday V, Caforio ALP, McKenna WJ: Familial dilated cardiomyopathy in the United Kingdom. Br Heart J 1995, 73:417-421.
8. Honda Y, Yokota Y, Yokoyama M: Familial aggregation of dilated cardiomyopathy: evaluation of clinical characteristics and prognosis. Jpn Circ J 1995, 59:589-598.
9. Gregori D, Rocco C, Di Lenarda A, Sinagra G, Miocic S, Camerini F, Mestroni L: Estimating the frequency of familial dilated cardiomyopathy and the risk of misclassification errors. Circulation 1996, 94:1-270.
10. Mestroni L, Krajinovic M, Severini GM, Milasin J, Pinamonti C, Rocco C, Vatta M, Falaschi A, Giacca M, Camerini F: Molecular genetics of dilated cardiomyopathies. Eur Heart J 1995, 16(suppl 0):5-9.
11. Zachara E, Caforio ALP, Carboni GP, Pellegrmi A, Pompili A, Del Porto G, Sciarra A, Bosman C, Boldrini R, Prati GL, McKenna WJ: Familial aggregation on idiopathic dilated cardiomyopathy: clinical features and pedigree analysis in 14 families. Br Heart J 1993, 69:129-135.
12. Mestroni L, Milasin J, Vatta M, Pinamonti B, Sinagra G, Rocco C, Matulic M, Falaschi A, Giacca M, Camerini F: Genetic factors in dilated cardiomyopathy. Arch Mal Coeur 1996, 89(suppl II):15-20.
13. Caforio ALP, Keeling PJ, Zachara E, Mestroni L, Camerini F, Mann JM, Bottazzo GF, McKenna WJ: Evidence from family studies for autoimmunity in dilated cardiomyopathy. Lancet 1994, 344:773-777.
14. Carlquist JF, Menlove RL, Murray MB, O'Connell JB, Anderson JL: HLA class II (DR and DQ) antigen associations in idiopathic dilated cardiomyopathy: validation study and meta-analysis of published HLA association studies. Circulation 1991, 83:515-522.
15. Krajinovic M, Mestroni L, Severini GM, Pinamonti B, Camerini F, Falaschi A, Giacca M: Absence of linkage between idiopathic dilated cardiomyopathy and candidate genes involved in the immune function in a large Italian pedigree. J Med Genet 1994, 31:766-771.
16. Mestroni L, Krajinovic M, Severini GM, Falaschi A, M.G., Cermini F: Molecular genetics of dilated cardiomyopathy. Herz 1994, 19:97-104.
17. Olson TM, Thibodeau SN, Lundquist PA, Schaid DJ, Michels VV: Exclusion of a primary gene defect at the HLA locus in familial idiopathic dilated cardiomyopathy. J Med Genet 1995, 32:876-880.
18. Krajinovic M, Pinamonti B, Sinagra G, Vatta M, Severini GM, Milasin J, Falaschi A, Camerini F, Giacca M, Mestroni L: Linkage of familial dilated cardiomyopathy to chromosome 9. Am J Hum Genet 1995, 57:846-852. After a large series of candidate genes were excluded, a genome-wide search was undertaken in a large autosomal-dominant FDC kindred and then extended to two other families with FDC. The FDC locus was mapped in the region 9q13-q22, with a multipoint lod score of 4.2.
19. Durand J-B, Bachinski LL, Bieling LC, Czernuszewicz GZ, Abchee AB, Yu QT, Tapscott T, Hill R, Ifegwu J, Marian AJ, et al.: Localization of a gene responsible for familial dilated cardiomyopathy to chromosome 1q32. Circulation 1995, 92:3387-3389. A large four generation family with autosomal-dominant FDC was studied with linkage analysis. The FDC locus was mapped in 1q32 with a multipoint lod score 0f 6.3.
20. Bowles KL, Gajarski R, Porter P, Goytia V, Bachinski L, Roberts R, Pignatelli R: Gene mapping of familial autosomal dominant dilated cardiomyopathy to chromosome 10q21-23. J Clin Invest 1996, 98:1355-1360. A large three-generation family with autosomal-dominant FDC associated with mitral prolapse was studied with linkage analysis. The FDC locus was mapped in 10q21-q23 with a two-point lod score of 3.91.
21. Graber HL, Unverferth DV, Baker PB, Rayan JM, Baba N, Wooley CF: Evolution of a hereditary cardiac conduction and muscle disorder: a study involving a family with six generations affected. Circulation 1986, 74:325-327.
22. Kass S, MacRae C, Graber HL, Sparks EA, McNamara D, Boudoulas H, Basson CT, Baker III PB, Cody RJ, Fishman MC, et al.: A gene defect that causes conduction system disease and dilated cardiomyopathy maps to chromosome 1p1-1q1. Nat Genet 1994, 7:546-551.
23. Olson TM, Keating MT: Mapping a cardiomyopathy locus to chromosome 3p22-p25. J Clin Invest 1996, 97:528-532. A large kindred with DC associated with rhythm and conduction abnormalities was studied with linkage analysis. The disease locus was mapped in chromosome 3p22-p25, with a two-point lod score of 6.09.
24. Ahn AH, Kunkel LM: The structural and functional diversity of dystrophin. Nat Genet 1993, 3:283-291.
25. Towbin JA, Hejtmancik F, Brink P, Gelb BD, Zhu XM, Chamberlain JS, McCabe ERB, Swift M: X-linked cardiomyopathy (XLCM): molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation 1993, 87:1854-1865.
26. Muntoni F, Cau M, Ganau A, Congiu R, Arvedi G, Mateddu A, Morrosu MG, Cianchetti C, Realdi G, Cao A, Melis MA: Deletion of dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N Engl J Med 1993, 329:921-925.
27. Berko B, Swift M: X-linked dilated cardiomyopathy. N Engl J Med 1987, 316:1186-1191.
28. Yoshida K, Ikeda SI, Nakamura A, Kagoshima M, Takeda S, Shoji S, Yanagisawa N: Molecular analysis of the Duchenne muscular dystrophy gene in patients with Becker muscular dystrophy presenting with dilated cardiomyopathy. Muscle Nerve 1993, 16:1161-1166.
29. Milasin J, Muntoni F, Severini GM, Bartolini L, Vatta M, Krajinovic M, Mateddu A, Angelini C, Camerini F, Falaschi A, Giacca M: A point mutation in the 5′ splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathy. Hum Mol Genet 1996, 5:73-79 X-linked DC caused by a point mutation (G to T) in the splice donor sequence (GT) of the first muscle exon-intron junction This sequence is completely conserved in eukaryotes. and the mutation inhibit the production of the muscle isoform mRNA.
30. Muntoni F, Wilson L, Marrosu MG, Cianchetti C, Mestroni L, Ganau A, Dubowitz V, Sewry C: A mutation in the dystrophin gene selectively affecting dystrophin expression in the heart. J Clin Invest 1995, 96:693-699.
31. Melacini P, Fanin M, Danieli GA, Fasoli G, Villanova C, Angelini C, Vitiello L, Miorelli M, Buja GF, Mostacciuolo ML, et al.: Cardiac involvement in Becker muscular dystrophy. J Am Coll Cardiol 1993, 22:1927-1934.
32. Mestroni L, Muntoni F, Milasin J, Di Lenarda A, Sinagra G, Rocco C, Vatta M, Matulic M, Falaschi A, Camerini F, Giacca M: Familial dilated cardiomyopathy with subclinical skeletal muscle involvement [abstract]. Circulation 1996, 94:1-271.
33. Ortiz Lopez R, Li H, Su J, Goytia V, Towbin JA: Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy (XLCM). Circulation 1997. in press. A missense mutation in exon 9 of the dystrophin gene causes XLDC The amino acid substitution is associated with a change in the dystrophin structure, which is predicted to functionally destabilize the protein and alter the flexibility of the cytoskeletal network.
34. Fadic R, Sunada Y, Waclawik AJ, Buck S, Lewandoski PJ, Campbell KP, Lotz BP: Brief report: deficiency of a dystrophin-associated glycoprotein (adhalin) in a patient with muscular dystrophy and cardiomyopathy. N Engl J Med 1996, 334:362-366.
35. Maeda M, Holder E, Lowes B, Bies RD: Dilated cardiomyopathy associated with deficiency of the cytoskeletal protein metavinculin. Circulation 1997, 95:17-20.
36. Johns DR: The other human gene: mitochondrial DNA and disease. Nat Med 1996, 2:1065-1068. Overview of the role and mechanisms of the mitochondrial DNA in causing human disorders.
37. Schowengerdt KO, Towbin JA: Genetic basis of inherited cardiomyopathies. Curr Opin Cardiol 1995, 10:312-321.
38. Leu(UUR). Lancet, 1991, 338:143-147.
39. Suomalainen A, Paetau A, Leinonen H, Majander A, Peltonen L, Somer H: Inherited dilated cardiomyopathy with multiple deletions of mitochondrial DNA. Lancet 1992, 340:1319-1320.
40. Remes AM, Hassinen IE, Ikäheimo MJ, Herva R, Hirvonen J, Peuhkurinen KJ: Mitochondrial DNA deletions in dilated cardiomyopathy: a clinical study employing endomyocardial sampling. J Am Coll Cardiol 1994, 23:935-942.
41. Santorelli FM, Mak S-C, El-Schahawi M, Casali C, Shanske S, Baram TZ, Madrid RE, DiMauro S: Maternally inherited cardiomyopathy associated with a novel mutation in the mitochondrial tRNA Lys gene (G8363A). Am J Hum Genet 1996, 58:933-939.
42. Grasso M, Fasani R, Diegoli M, Bianchieri N, Porcu E, Concardi M, Pilotto A, Fortina P, Surrey S, Vigano M, Arbustini E: Mitochondrial DNA base changes in sporadic and familial dilated cardiomyopathy (DCM) and in controls [abstract]. J Mol Med 1995, 73:A28
43. McKenna WJ, Thiene G, Nava A, Fontaliran F, Blomstrom-Lunqvist C, Fontaine G, Camerini F: Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Br Heart J 1994, 71:215-218.
44. Mallat Z, Tedgui A, Fontaliran F, Frank R, Durigon M, Fontaine G: Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N Engl J Med 1996, 335:1190-1196.
45. Rampazzo A, Nava A, Danieli GA, Buja G, Dahento L, Fasoli G, Scognamiglio R, Corrado D, Thiene G: The gene for arrhythmogenic right ventricular cardiomyopathy maps to chromosome 14q23-q24. Hum Mol Genet 1994, 3:959-962.
46. Rampazzo A, Nava A, Erne P, Eberhard M, Vian E, Slomp P, Tiso N, Thiene G, Daniel GA: A new locus for arrhythmogenic right ventricular cardiomyopathy (ARVD2) maps to chromosome 1q42-q43. Hum Mol Genet 1995, 4:2151-2154. After the identification of a first locus containing the gene for ARVD (ARVD1), the same authors found a second disease locus on chromosome 1q42-q43 in another family, with a maximum multipoint lod score of 5.02.
47. Severini GM, Krajinovic M, Pinamonti B, Sinagra G, Fioretti P, Brunazzi MC, Falaschi A, Camerini F, Giacca M, Mestroni L: A new locus for arrhythmogenic right ventricular dysplasia on the long arm of chromosome 14. Genomics 1996, 31:193-200. Further evidence of genetic heterogeneity in right ventricular dysplasia: the locus ARVD3 is mapped in chromosome 14q12-q22 in three families. The multipoint lod score was 4.7.+